Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Biological & Pharmaceutical Bulletin|April 4, 2000
Z-335, a thromboxane A2 receptor antagonist, suppresses the progression of arachidonic acid-induced hind limb gangrene in ratsT Tanaka, Y Fukuta, Y Fukuda, et al.
No Shinkei Geka. Neurological Surgery|July 1, 1987
[Treatment of craniofacial fractures]T Nishiyama, K Kawakami, K Kawamoto, et al.
European Journal of Pharmacology|August 30, 2001
Pharmacodynamic analysis of steroid 5alpha-reductase inhibitory actions of Z-350 in rat prostateS Furuta, Y Fukuda, T Sugimoto, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
Effects of citalopram, a synthetic serotonin uptake inhibitor, on indoleamine and catecholamine concentrations in the cerebrospinal fluid of freely moving ratsH Tohgi, T Abe, M Nakanishi, et al.
No Shinkei Geka. Neurological Surgery|July 1, 1981
[Intracranial hemorrhage caused by metastatic brain tumors (author's transl)]Y Yamanouchi, T Kurimoto, J Suwa, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|June 1, 1995
[Effect of efonidipine hydrochloride, a calcium channel blocker, on the experimental cerebral ischemia/anoxia]T Matsumura, H Furuichi, J Izumi, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 1, 1993
[Effects of NC-1100, a calcium channel blocker, on experimental cerebral ischemia/anoxia in rodents]T Matsumura, H Furuichi, J Izumi, et al.
European Journal of Pharmacology|October 27, 1998
Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonistT Tanaka, Y Fukuta, R Higashino, et al.
Pageof 18